InsiderTrades.com logo
Could This Tiny Device Help You Make an Extra $30k a Year?
From Brownstone Research   |   Ad
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.
Click here to see the details because I believe a lot of people will get rich.

GYRE Insider Trading

Insider Ownership Percentage: 19.52%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $367,764.00

Gyre Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Gyre Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Gyre Therapeutics Share Price & Price History

Current Price: $11.90
Price Change: ▼ Price Decrease of -0.3 (-2.46%)
As of 12/24/2024 02:00 PM ET

This chart shows the closing price history over time for GYRE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
From Behind the Markets   |   Ad
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
Click here for the ticker >>>

Gyre Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/19/2024Songjiang MaPresidentSell2,000$10.82$21,640.002,936,467View SEC Filing Icon  
12/17/2024Songjiang MaPresidentSell2,000$11.05$22,100.002,940,467View SEC Filing Icon  
6/28/2024Nassim UsmanDirectorSell3,452$12.00$41,424.001,636View SEC Filing Icon  
5/1/2024Nassim UsmanDirectorSell20,000$14.13$282,600.001,636View SEC Filing Icon  
See Full Table
Could This Tiny Device Help You Make an Extra $30k a Year?
From Brownstone Research   |   Ad
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.
Click here to see the details because I believe a lot of people will get rich.

SEC Filings (Institutional Ownership Changes) for Gyre Therapeutics (NASDAQ:GYRE)

23.99% of Gyre Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GYRE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Gyre Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC9,288$0.12M0.0%+281.8%0.010%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC303,647$3.81M0.0%+16.9%0.325%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC9,288$0.12M0.0%+281.8%0.010%Search for SEC Filing on Google Icon
11/15/2024State Street Corp104,490$1.31M0.0%+8.8%0.112%Search for SEC Filing on Google Icon
11/13/2024FMR LLC3,742$47K0.0%N/A0.004%Search for SEC Filing on Google Icon
11/13/2024Advantage Alpha Capital Partners LP26,634$0.33M0.1%N/A0.029%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.113,648$1.43M0.0%+392.2%0.122%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP10,720$0.13M0.0%-58.0%0.013%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC13,900$0.17M0.0%N/A0.016%Search for SEC Filing on Google Icon
8/9/2024WINTON GROUP Ltd18,467$0.22M0.0%N/A0.022%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers10,291$0.12M0.0%N/A0.012%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp18,266$0.22M0.0%N/A0.021%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.195,098$3.41M0.0%-1.5%0.228%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Gyre Therapeutics logo
Gyre Therapeutics, Inc., a biopharmaceutical company, primarily focuses on the development and commercialization of Hydronidone for the treatment of Metabolic Dysfunction Associated Steatohepatitis in the United States. Its Hydronidone is also being evaluated for the treatment of liver fibrosis across a spectrum of chronic liver diseases. In addition, it advances a product pipeline in China, including Pirfenidone, for dermatomyositis interstitial lung disease, systemic sclerosis-associated interstitial lung disease, and pneumoconiosis, as well as for diabetic kidney disease; and product candidates for acute-on-chronic liver failure, chronic obstructive pulmonary disease, and pulmonary arterial hypertension. The company was founded in 2002 and is headquartered in San Diego, California.
Read More on Gyre Therapeutics

Today's Range

Now: $11.90
Low: $11.76
High: $12.22

50 Day Range

MA: $12.83
Low: $9.64
High: $16.80

52 Week Range

Now: $11.90
Low: $8.26
High: $30.39

Volume

50,606 shs

Average Volume

74,964 shs

Market Capitalization

$1.11 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.99

Who are the company insiders with the largest holdings of Gyre Therapeutics?

Gyre Therapeutics' top insider investors include:
  1. Songjiang Ma (President)
  2. Nassim Usman (Director)
Learn More about top insider investors at Gyre Therapeutics.

Who are the major institutional investors of Gyre Therapeutics?

Gyre Therapeutics' top institutional shareholders include:
  1. Geode Capital Management LLC — 0.33%
  2. Charles Schwab Investment Management Inc. — 0.12%
  3. State Street Corp — 0.11%
  4. Advantage Alpha Capital Partners LP — 0.03%
  5. Belvedere Trading LLC — 0.00%
  6. Barclays PLC — 0.01%
Learn More about top institutional investors of Gyre Therapeutics stock.

Which major investors are buying Gyre Therapeutics stock?

In the last quarter, GYRE stock was acquired by institutional investors including:
  1. Charles Schwab Investment Management Inc.
  2. Geode Capital Management LLC
  3. Advantage Alpha Capital Partners LP
  4. State Street Corp
  5. Barclays PLC
  6. Barclays PLC
  7. FMR LLC
Could This Tiny Device Help You Make an Extra $30k a Year?
From Brownstone Research   |   Ad
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.
Click here to see the details because I believe a lot of people will get rich.